Please login to the form below

Not currently logged in
Email:
Password:

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

QiC Excellence in Oncology

Finalists for the first QiC Excellence in Oncology awards have been announced, each demonstrating an example of good practice in cancer care throughout the UK.

In total, there are 39 finalists spanning 10 categories, including the cancer commissioning award, cancer team of the year and patient experience.

Represented among the finalists in cancer charity initiative of the year were Macmillan Cancer Support, testicular cancer awareness campaign It's in the Bag and HeadSmart to raise awareness of brain tumours.

And those down to final five for cancer journalist of blogger of the year included Linda Geddes of New Scientist, freelance writer Judy Hobson and cancer blogger Mike Baker.

QiC Excellence in Oncology is an evolution of Pfizer's Excellence in Oncology awards, and aims to recognise individuals or teams involved in the support, care and treatment of cancer patients in the UK.

It is supported by Cancer 52, Beating Bowel Cancer, the National Cancer Action Team, and has industry partners such as Pfizer, BMS and Novartis.

Winners will be announced on November 6 at The Hilton, Liverpool, during the National Cancer Research Institute's (NCRI) annual conference.

14th September 2012

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...